Objective To compare misoprostol with standard oxytocic regimens in the prevention of
postpartum haemorrhage. Design Randomised controlled trial. Setting Obstetric unit in a …

Objective To compare oral misoprostol 400 μg with placebo in the routine management of
the third stage of labour. Design A double‐blind placebo controlled trial. Setting The labour …

This is a multicentre, blocked, randomized trial to compare the efficacy of oral misoprostol
400μg with current injectable uterotonic agents (oxytocin/Syntometrine) used …

Our objective was to compare oral misoprostol with intramuscular oxytocin in the prevention
of postpartum haemorrhage. Four hundred and ninety-six women were randomised to …

Objective: To investigate whether orally administered misoprostol during the third stage of
labor is efficient in reducing postpartum blood loss. Methods: In a double-masked trial …

Postpartum haemorrhage remains a leading cause of maternal mortality, despite treatment
with conventional methods. In this randomised controlled trial, we compared misoprostol …

OBJECTIVE: To assess the effects of prophylactic misoprostol use in the third stage of labor
compared with injectable uterotonics or placebo or no treatment. DATA SOURCES: The …

Objective: To compare the effectiveness of 400 μg rectal misoprostol in 5 cm3 of saline with
oxytocin 10 IU, im, in reducing bleeding during the third stage of labor. Design: A double …

Objective To compare the efficacy and side effects of misoprostol, compared with
methylergometrine, for the prevention of postpartum haemorrhage. Design A double–blind …

Background Postpartum haemorrhage remains an important cause of maternal death
despite treatment with conventional therapy. Uncontrolled studies and one randomised …